BCWorldPharm Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
30,375
35,692
41,415
45,658
50,207
Cost of Goods Sold (COGS) incl. D&A
15,470
18,203
20,705
23,306
26,646
Gross Income
14,905
17,489
20,710
22,352
23,562
SG&A Expense
10,765
12,178
14,090
15,433
14,675
EBIT
4,048
5,262
6,616
6,911
8,874
Unusual Expense
24
33
100
35
79
Non Operating Income/Expense
39
45
641
46
151
Interest Expense
823
816
110
215
259
Pretax Income
3,358
4,618
6,022
6,729
8,568
Income Tax
24
877
304
255
503
Consolidated Net Income
3,335
3,742
6,326
6,475
8,065
Net Income
3,335
3,742
6,326
6,475
8,083
Net Income After Extraordinaries
3,335
3,742
6,326
6,475
8,083
Net Income Available to Common
3,335
3,742
6,326
6,475
8,083
EPS (Basic)
497.00
558.00
822.31
917.22
1,051.00
Basic Shares Outstanding
8
8
8
7
8
EPS (Diluted)
462.42
461.01
822.72
917.01
1,044.64
Diluted Shares Outstanding
8
8
8
7
8
EBITDA
5,284
6,577
7,994
8,646
11,489
Other Operating Expense
92
48
5
8
13
Non-Operating Interest Income
196
95
258
44
25
Minority Interest Expense
-
-
-
-
17
About BCWorldPharm Co.
View Profile
